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Abstract
Mycoplasma synoviae infection in chickens and turkeys can cause respiratory disease,
infectious synovitis and eggshell apex abnormality; thus it is an economically important
pathogen. Control ofM. synoviae infection comprises eradication, medication or vaccina-
tion. The differentiation of the temperature sensitive (ts+) MS-H vaccine strain from field iso-
lates is crucial during vaccination programs. Melt-curve and agarose gel based mismatch
amplification mutation assays (MAMA) are provided in the present study to distinguish
between the ts+ MS-H vaccine strain, its non-temperature sensitive re-isolates and wild-
typeM. synoviae isolates based on the single nucleotide polymorphisms at nt367 and nt629
of the obg gene. The two melt-MAMAs and the two agarose-MAMAs clearly distinguish the
ts+ MS-H vaccine strain genotype from its non-temperature sensitive re-isolate genotype
and wild-typeM. synoviae isolate genotype, and no cross-reactions with otherMycoplasma
species infecting birds occur. The sensitivity of the melt-MAMAs and agarose-MAMAs was
103 and 104 copy numbers, respectively. The assays can be performed directly on clinical
samples and they can be run simultaneously at the same annealing temperature. The
assays can be performed in laboratories with limited facilities, using basic real-time PCR
machine or conventional thermocycler coupled with agarose gel electrophoresis. The
advantages of the described assays compared with previously used methods are simplicity,
sufficient sensitivity, time and cost effectiveness and specificity.
Introduction
Mycoplasma synoviae can cause respiratory disease, infectious synovitis and eggshell apex
abnormality in chickens and turkeys, thus the bacterium has economic importance in poultry
industry.M. synoviae infection may occur from sub-clinical to severe forms, and the clinical
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signs change markedly whenMycoplasma infection is associated with other pathogens [1–3].
M. synoviae has a worldwide distribution and its occurrence is increasing. Less attention paid
to control programs, biosecurity lapses at farms and large concentration of poultry in small
geographic areas could accelerate the spread ofM. synoviae infection [4].M. synoviaemay be
transmitted either vertically through the eggs, or laterally by direct contact or indirect contact
via the environment [1,5]. There are three general aspects in the control ofM. synoviae infec-
tion: eradication and maintaining pathogen-free status by prevention, medication or vaccina-
tion [4].
In situations where maintaining flocks free ofM. synoviae is not feasible (e.g. at a multi-age
commercial layer farm) vaccination is a practical option for infection control. The commer-
cially available live attenuated vaccine contains the temperature sensitive (ts+) MS-H strain
(Vaxsafe MS-H, Bioproperties Pty. Ltd. Australia), and it is used in many countries [6,7]. To
perform control and eradication programs, molecular typing techniques have to be able to dif-
ferentiate the ts+ MS-H vaccine strain from field isolates. It is also important to examine
whether the vaccine strain has successfully colonized the respiratory mucosa and thus pro-
duced an efficient immune response against wild-type strains. The sequence analysis of the
vlhA gene was widely used to differentiate the MS-H vaccine strain from clinical isolates [8–
11]. Unfortunately, it turned out that the vlhA gene sequence profile of the MS-H vaccine strain
is not unique and several Australian and European field strains share the same vlhA gene
sequence [9,12].
Shahid and co-workers [13] discovered two single nucleotide polymorphisms (SNP) on the
obg gene sequence, namely the A-G substitution at nt367 and C-T substitution at nt629 which
are able to differentiate the ts+ MS-H vaccine strain, its rare non-temperature sensitive (ts-)
MS-H re-isolates and wild-typeM. synoviae isolates. They developed four PCRs followed by
high-resolution melting (HRM)-curve analysis for the differentiation of strains based on these
SNPs [7]. Although these PCR-HRM assays work well, we think they can be simplified and
new assays can be designed for efficient use on basic laboratory equipment. Therefore in our
study we provide melt-curve and agarose gel based mismatch amplification mutation assays
(MAMA) to distinguish the ts+ MS-H vaccine strain, ts- MS-H re-isolates and wild-typeM.
synoviae isolates based on the substitutions at nt367 and nt629 of the obg gene.
Methods
MAMAs are used for SNP typing in many different pathogens. The detailed description of the
method is presented elsewhere [14]. In brief, MAMAs are based on allele-specific primers that
are SNP specific at the 3’end. A single base mismatch at the ante-penultimate (-3) position of
each allele-specific primer enhances the SNP discrimination capacity of these assays. One
allele-specific primer possesses an additional 15-20bp GC-clamp at the 5’end with a sequence
of CGGGG and the other allele primer has no additional sequence. The GC-clamp increases
the melting temperature (Tm) of the resulting PCR product by 3–5°C, a shift that is detectable
by fluorescent dye on a real-time PCR platform (Melt-MAMA) and it increases the size of the
PCR product, resulting in a size difference which can also be detected by 3% agarose gel elec-
trophoresis (Agarose-MAMA).
In the present study MAMAs were designed and tested to detect the nt367 and nt629 SNPs
in the obg gene ofM. synoviae. The genome locations, primer sequences, annealing and melting
temperatures for these assays can be found in Tables 1 and 2. Melt-MAMA PCR reactions
were performed in 10 μl total volume, containing 1μl target DNA diluted in 2 μl 5X Color-less
GoTaq Flexi Buffer (Promega Inc., Madison, WI), 1 μl MgCl2 (25mM), 0.3 μl dNTP (10 mM,
Qiagen Inc., Valencia, CA), 0.5 μl EvaGreen (Biotium Inc., Hayward, CA), primers (10 pmol/
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μl) according to Table 1 and 0.08 μl GoTaq DNA polymerase (5 U/μl; Promega). Melt-
MAMAs were performed on an Applied Biosystems Step-One Plus real-time PCR system with
StepOne Softwarev2.2.2. Thermocycling parameters were 95°C for 10 min, followed by 39
cycles of 95°C for 15 sec and 58°C for 1 min. Endpoint PCR products were subjected to melt
analysis using a dissociation protocol comprising 95°C for 15 sec, followed by incremental tem-
perature ramping (0.2°C) from 58°C to 95°C. EvaGreen fluorescent intensity was measured at
525 nm at each ramp interval and plotted against temperature.
Agarose-MAMAs were performed in Biometra–T Personal thermal cycler (Biometra Inc.,
Göttingen, Germany) in 25 μl total volume, containing 1 μl target DNA diluted in 5 μl 5X
Green GoTaq Flexi Buffer (Promega Inc., Madison, WI), 2.5 μl MgCl2 (25mM), 0.5 μl dNTP
(10 mM, Qiagen Inc., Valencia, CA), primers (10 pmol/μl) according to Table 2 and 0.25 μl
GoTaq DNA polymerase (5 U/μl; Promega). Thermocycling parameters were 94°C for 5 min,
followed by 40 cycles at 94°C for 30 sec, 58°C for 30 sec and 72°C for 30 sec. The final elonga-
tion step was performed at 72°C for 5 min. Electrophoresis was performed in 3% agarose gel
(MetaPhor Agarose, Lonza Group Ltd., Basel, Switzerland) and a 20-bp DNA ladder (O'Ran-
geRuler 20 bp, Thermo Fisher Scientific Inc.) was used as molecular weight marker.
In order to test the sensitivity of the assays, 10 fold dilutions of gBlocks (Integrated DNA
Technologies Inc., Coralville, IA) containing 200 ng of a 330 bp long fragment of the obg gene
(from nt342 to nt672) were used (Fig 1). The specificity of the assays was tested by including
the following avianMycoplasma species in the analysis:M. anatis,M. anseris,M. columbina-
sale,M. columborale,M. cloacale,M. gallinaceum,M. gallinarum,M. gallisepticum,M.
Table 1. SNP locations in the obg gene, SNP state, primer sequences, primer volumes and thermal cycler parameters for the two MS-Hmelt-
MAMAs.
Assay
name
SNP
position
SNP
state
MAMA
primer
names
MAMA primer sequences Primer
(10 pmol/µl)
volume in
10 µl reaction
mixture (µl)
Annealing
temperature
(°C)
Melting
temperature
(°C)
MS-H1 367 G/A
MS-H1-poz ggggcggggcggggcGCTAAAGGCGGAAAAGtCa 0.600
58
80.1
MS-H1-neg GCTAAAGGCGGAAAAGaCg 0.150 75.0
MS-H1-R GGCAATTCTAGGAGCGGT 0.150
MS-H2 629 C/T
MS-H2-poz ggggcggggcggggCTTTAATAAGYCCAGGAAGATaCg 0.150
58
76.8
MS-H2-neg CTTTAATAAGYCCAGGAAGATtCa 0.150 70.9
MS-H2-R CCTTAGTTCCTCAGTTAGGTCTTG 0.150
doi:10.1371/journal.pone.0133554.t001
Table 2. SNP locations in the obg gene, SNP state, primer sequences and primer volumes for the two MS-H agarose-MAMAs.
Assay
name
SNP
position
SNP
state
MAMA
primer
names
MAMA primer sequences Primer (10 pmol/µl)
volume in 25 µl
reaction mixture
(µl)
Annealing
temperature
(°C)
MS-H1 367 G/A
MS-H1-poz-
agarose
ggggcggggcggggcggggcGCTAAAGGCGGAAAAGtCa 3
58
MS-H1-neg GCTAAAGGCGGAAAAGaCg 1
MS-H1-R GGCAATTCTAGGAGCGGT 1
MS-H2 629 C/T
MS-H2-poz-
agarose
ggggcggggcggggcggggCTTTAATAAGYCCAGGAAGATaCg 1
58
MS-H2-neg CTTTAATAAGYCCAGGAAGATtCa 3
MS-H2-R CCTTAGTTCCTCAGTTAGGTCTTG 1
doi:10.1371/journal.pone.0133554.t002
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gallopavonis,M. iners,M. iowae,M.meleagridis andM. sp. 1220. The temperature sensitive
(ts+) MS-H vaccine strain (Vaxsafe MS-H),M. synoviae type strain (WVU 1835, NCTC
10124), seven clinicalM. synoviae isolates (3 chicken and 4 turkey isolates), nine ts+ MS-H re-
isolates and trachea swabs taken from 40 vaccinated and 40 clinically infected (seropositive)
chickens were included in the analysis as well (Table 3). DNA was extracted from the isolated
strains and trachea swabs with the Qiamp DNAMini kit (Qiagen GmbH, Hilden, Germany).
Ethical approval was not required for the study as all samples and strains were collected by the
authors during routine diagnostic examinations.
Results
Both melt-MAMAs clearly differentiated the ts+ MS-H vaccine strain genotype, ts- MS-H re-
isolate genotype and wild-typeM. synoviae strain genotype (Table 4). The MS-H1 assay (nt367
SNP position) distinguished ts+ MS-H vaccine strain and ts- MS-H re-isolates from wild-type
Fig 1. Sequences of the gBlocks used as positive and validation controls in the study. The gBlocks
(Integrated DNA Technologies Inc., Coralville, IA) contain 330 bp long fragment of the obg gene between
nt342 and nt672.
doi:10.1371/journal.pone.0133554.g001
Table 3. Background information of theMycoplasma synoviae strains, ts+ MS-H re-isolates and trachea swab samples included in this study.
Sample ID Sample type Sample source Location of sampled farm in Hungary Collection date
MS 1 Mycoplasma synoviae strain chicken trachea Széchényfelfalud 2014
MS 2 Mycoplasma synoviae strain chicken trachea Szentmártonkáta 2015
MS 3 Mycoplasma synoviae strain chicken trachea Jászapáti 2015
MS 4 Mycoplasma synoviae strain turkey trachea Völcsej 2014
MS 5 Mycoplasma synoviae strain turkey trachea Simaság 2014
MS 6 Mycoplasma synoviae strain turkey trachea Ács 2014
MS 7 Mycoplasma synoviae strain turkey trachea Bőny 2014
MS-VR1-VR5 ts+ MS-H re-isolates chicken trachea Tárkány (farm-1-5) 2015
MS-VR6-VR9 ts+ MS-H re-isolates chicken trachea Bábolna (farm-1-4) 2015
MS S1-S10 trachea swabs from seropositive animals chicken trachea Széchényfelfalud 2014
MS S11-S20 trachea swabs from seropositive animals chicken trachea Szentmártonkáta 2015
MS S21-S30 trachea swabs from seropositive animals chicken trachea Jászapáti 2015
MS S31-S40 trachea swabs from seropositive animals chicken trachea Hegyeshalom 2015
MS V1-V10 trachea swabs from vaccinated animals chicken trachea Tárkány (farm-1) 2015
MS V11-V20 trachea swabs from vaccinated animals chicken trachea Tárkány (farm-2) 2015
MS V21-V30 trachea swabs from vaccinated animals chicken trachea Bábolna (farm-1) 2015
MS V31-V40 trachea swabs from vaccinated animals chicken trachea Bábolna (farm-2) 2015
doi:10.1371/journal.pone.0133554.t003
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M. synoviae isolates with 80.1°C and 75.0°C melting temperatures, respectively (Fig 2). The
MS-H2 assay (nt629 SNP position) distinguished ts+ MS-H vaccine strain and wild-type
M. synoviae strains from ts- MS-H re-isolates with 76.8°C and 70.9°C melting temperatures,
respectively (Fig 3). The agarose-MAMA versions of the MS-H1 and MS-H2 assays also differ-
entiated the ts+ MS-H vaccine strain genotype, ts- MS-H re-isolate genotype and wild-typeM.
synoviae strain genotype based on the 19-20bp fragment size differences of the PCR products
obtained from certain genotypes (Table 4 and Fig 4).
The sensitivity of both MS-H1 and MS-H2 melt-MAMAs was 103 copy numbers, while
both the MS-H1 and MS-H2 agarose-MAMAs showed a sensitivity of 104 copy numbers. Nei-
ther assay cross-reacted with the other tested avianMycoplasma species. TheM. synoviae type
strain (WVU 1835, NCTC 10124), the seven clinicalM. synoviae isolates and 35 out of 40 tra-
chea swabs taken from clinically infected chickens showed the wild-type strain profile while
the ts+ MS-H vaccine strain (Vaxsafe MS-H), the nine ts+ MS-H re-isolates and 38 out of 40
trachea swabs taken from vaccinated chickens showed a ts+ MS-H vaccine strain profile in the
melt and agarose-MAMAs. These results were confirmed by sequencing of the obg gene of
these samples as well (data not shown).
Discussion
M. synoviae causes infectious synovitis, airsacculitis and eggshell apex abnormality in chickens
and turkeys, which eventually result in significant economic losses. The ts+ MS-H vaccine
strain is used worldwide in order to reduce economic losses and to eliminate wild-typeM. syno-
viae strains from poultry farms. The ability to differentiate the vaccine strain from wild-type
isolates is essential for the evaluation of the effect of vaccination and eradication programs.
Table 4. Matrix showing the SNP states, melt-MAMAmelting temperatures (Tm) and agarose-MAMA PCR fragment sizes in the ts
+ MS-H vaccine
strain genotype, ts- MS-H re-isolate genotype and wild-typeM. synoviae strain genotype.
Strain
genotypes
nt367 SNP
state
nt629 SNP
state
MS-H1 melt-
MAMA Tm (°C)
MS-H2 melt-
MAMA Tm (°C)
MS-H1 agarose-MAMA PCR
fragment size (bp)
MS-H2 agarose-MAMA PCR
fragment size (bp)
ts+ MS-H vaccine
strain
A C 80.1 76.8 91 96
ts- MS-H re-
isolatea
A T 80.1 70.9 91 77
wild-type strainb G C 75.0 76.8 71 96
aand rare 94036-2-1a genotype ts+ MS-H re-isolates [7,13].
band MS-H4 like genotype ts- MS-H re-isolates [7,13].
doi:10.1371/journal.pone.0133554.t004
Fig 2. Amplification plot andmelting-curves of MS-H1melt-MAMA. Amplification plot (A) of dilution
series of gBlock validation controls showing the sensitivity of the MS-H1 assay. Green line represents
negative control. Melting curves (B) showmelting temperatures for the temperature sensitive MS-H vaccine
strain and non-temperature sensitive MS-H re-isolate (Tm: 80.1°C; blue line) or wild-type strain (Tm: 75.0°C;
orange line).
doi:10.1371/journal.pone.0133554.g002
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Micro-titrating, incubating and quantifying the isolated strains at two different tempera-
tures in order to differentiate the ts+ MS-H vaccine strain from the ts- MS-H re-isolates and
wild-type strains is time-consuming [6,15]. The sequence analysis of the vlhA gene with differ-
ent assays is a widely used method to differentiateM. synoviae isolates. However, this is also a
relatively time-consuming and expensive method, but its biggest pitfall is that it is unable to
distinguish several Australian and European wild-typeM. synoviae isolates and ts- MS-H re-
isolates from the ts+ MS-H vaccine strain [7,9,12].
Shahid and co-workers [7,13] discovered two specific SNPs on the obg gene and developed
HRM-curve analysis based assays to differentiate the ts+ MS-H vaccine strain, ts- MS-H re-iso-
lates and wild-typeM. synoviae strains. In the current study we presented novel genotyping
assays targeting these two SNPs on the obg gene which clearly differentiate the ts+ MS-H vac-
cine strain, ts- MS-H re-isolates and wild-typeM. synoviae strains. Our assays are specific and
sensitive enough (103−104 copy numbers) to detect and describeM. synoviae strains, when
wild or vaccine strains are present as single specific pathogen in the sample. We also think that
our assays are preferable to the assays developed earlier for the following three reasons: they
are rapid, they can be performed directly on clinical samples (e.g. swabs) and the assays can be
run simultaneously at the same annealing temperature. They are also simple as they can be per-
formed on basic real-time PCR machines (without the HRM-curve analysis function) and on
conventional PCR equipment coupled with agarose gel electrophoresis. They are cost effective
Fig 3. Amplification plot andmelting-curves of MS-H2melt-MAMA. Amplification plot (A) of dilution
series of gBlock validation controls showing the sensitivity of the MS-H2 assay. Green line represents
negative control. Melting curves (B) showmelting temperatures for the temperature sensitive MS-H vaccine
strain and a wild-type strain (Tm: 76.8°C; blue line) or non-temperature sensitive MS-H re-isolate (Tm:
70.9°C; orange line).
doi:10.1371/journal.pone.0133554.g003
Fig 4. PCR product sizes of MS-H1 and MS-H2 agarose-MAMAs in agarose gel. Electrophoresis was
performed in 3% agarose gel (MetaPhor Agarose, Lonza Group Ltd., Basel, Switzerland) and a 20-bp DNA
ladder (O'RangeRuler 20 bp, Thermo Fisher Scientific Inc.) was used as molecular weight marker (m). In the
MS-H1 assay gBlock-B and a wild-type strain yielded 71 bp fragments, while gBlock-A and the temperature
sensitive MS-H vaccine strain produced 91 bp fragments. In the MS-H2 assay gBlock-B (non-temperature
sensitive MS-H re-isolate homologue) yielded 77 bp fragment, while gBlock-A, the temperature sensitive
MS-H vaccine strain and wild-type strains give 96 bp fragments.
doi:10.1371/journal.pone.0133554.g004
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as they do not require the expensive culture process, PCR product sequencing or costly
reagents (e.g. TaqMan probes).
Unfortunately, besides the above listed advantages, the presented methods also have their
pitfalls similarly to previous assays based on the obg gene. Namely, the MS-H4 like genotype ts-
MS-H re-isolates show the same obg gene profile as wild-type isolates, and the rare 94036-2-1a
genotype ts+ MS-H re-isolates show the same obg gene profile as the average ts- MS-H re-iso-
lates. These re-isolates can only be ascertained by using vlhA gene based HRM assay in combi-
nation with obg gene based assays (Table 4) [7,9,13]. Another pitfall is that the genotyping of
mixed infections (e.g. wild type strain superinfected vaccine strain) is unreliable because of the
characteristics of the MAMAmethod (e.g. competing primers).
We hope that the presented assays will be helpful for both well-equipped laboratories and
those with basic facilities throughout the world to differentiate the ts+ MS-H vaccine strain,
ts-MS-H re-isolates and wild-typeM. synoviae strains and thus facilitateM. synoviae control
programs.
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